Lawmakers have yet to reach an agreement on a deal to make affordable insulin more available in the state. State representative Jeff Brand of St. Peter says he prefers the house plan.

“I received a letter from Mankato Clinic a few weeks ago saying the Senate bill would cost them one-hundred thousand dollars per year, ” said Brand. “That additional cost would be in storage and hiring someone to manage the insulin on site. The House bill makes the manufacturers of the insulin pay for it.”

Brand says he has concerns regarding the way the insulin prices have gone up the last couple of years. He says the House bill puts the accountability on the manufactures of insulin rather than adding a cost to the health care provider.